文献速递妇科生殖医学

影响妇科恶性肿瘤保留生育功能治疗的因素:妇科肿瘤学会会员调查

Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.
PubMed 文献 · Gynecol Oncol · 2017-09-21

本研究向1087名妇科肿瘤医生发放匿名23题问卷,完成率14.0%,旨在调查其对妇科恶性肿瘤保留生育功能治疗(FST)的实践模式及与生殖内分泌医生(RE)合作的態度。结果显示多数医生提供FST;接诊育龄女性数量更多者更常考虑癌症预后(p<0.03)和分期(p<0.01);美国中西部医生比南部更常考虑社会经济地位(p<0.04);城市执业者更认为治疗前与RE合作可改善治疗规划(p<0.02),城市或郊区医生比农村更常认为合作改善妊娠结局(p<0.01,p<0.02)。

要点

  • 多数妇科肿瘤医生为妇科恶性肿瘤患者提供保留生育功能治疗。
  • 接诊育龄女性数量更多者更常将癌症预后和分期作为关键因素。
  • 城市或郊区医生比农村医生更认可与生殖内分泌医生合作改善妊娠结局。

核心结论

  • 多数妇科肿瘤医生提供FST,但影响是否提供FST及是否寻求与RE合作的因素数据极少。
  • 接诊育龄女性数量、地理区域和执业环境是可能影响当前实践的重要变量。
  • 理解这些因素有助于识别改善该患者群体肿瘤和生殖结局的机会。

研究设计与样本

  • 向1087名妇科肿瘤医生发放匿名23题问卷,完成率14.0%。
  • 使用描述性统计、Fisher精确检验和卡方检验进行数据分析。

主要发现

  • 接诊育龄女性数量更多的医生更可能将癌症预后(p<0.03)和癌症分期(p<0.01)视为关键因素。
  • 美国中西部医生比南部医生在提供FST时更常考虑社会经济地位(p<0.04)。
  • 城市执业者更可能认为治疗前与RE合作可改善考虑FST的女性的治疗规划(p<0.02)。
  • 城市或郊区执业者比农村执业者更常认为与RE合作改善追求FST女性的妊娠结局(p<0.01,p<0.02)。

关键数值与推荐

  • 多数妇科肿瘤医生为妇科恶性肿瘤提供FST。
  • 接诊育龄女性数量更多的医生更可能考虑癌症预后(p<0.03)和癌症分期(p<0.01)。
  • 美国中西部医生比南部医生更常考虑社会经济地位(p<0.04)。
  • 城市执业者更可能认为治疗前与RE合作可改善治疗规划(p<0.02)。
  • 城市或郊区执业者比农村执业者更常认为与RE合作改善妊娠结局(p<0.01,p<0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aims to examine practice patterns of gynecologic oncologists (GO) regarding fertility-sparing treatments (FST) for gynecology malignancies and explores attitudes toward collaboration with reproductive endocrinologists (RE). METHODS: An anonymous 23-question survey was sent to 1087 GO with a 14.0% completion rate. Descriptive statistics, Fisher's exact test, and Chi-square tests were used for data analysis. RESULTS: The majority of GOs offer FST for gynecologic malignancies. Providers seeing larger numbers of reproductive age women were more likely to consider cancer prognosis (p<0.03) and cancer stage (p<0.01) as key factors. Providers in the Midwestern US considered socioeconomic status more often when offering FST than those in the South (p<0.04). Those practicing in urban settings were more likely to feel that collaborating with a RE prior to treatment could improve treatment planning for women considering FST (p<0.02). Finally, providers in urban or suburban areas more often felt collaboration with a RE improves pregnancy outcomes in women who pursue FST (p<0.01, p<0.02) compared to rural practitioners. CONCLUSIONS: While FST offers women the chance to pursue pregnancy after cancer, there are minimal data on factors that influence whether FST is offered and if collaboration with a RE is sought in the management of these patients. The number of reproductive age women seen, geographic location, and practice setting are important variables that may influence current practice. Understanding these factors can help identify opportunities to improve oncologic and reproductive outcomes of this patient population.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Shah JS, Guerra R, Bodurka DC, et al. Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members. Gynecol Oncol. 2017. PMID: 28941656. doi:10.1016/j.ygyno.2017.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。